Skip to main content
. 2019 May 7;15(10):2243–2248. doi: 10.1080/21645515.2019.1602431

Table 1.

List of successful flavivirus vaccines commercially available on the market.

Disease Commercial Name of Vaccine Vaccine Type Manufacturer Countries available
Yellow Fever 17DD Live attenuated Bio-Manguinhos, Brazil Brazil
17D–204 (Stamaril® in Senegal) Sanofi Pasteur France France
Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE), Moscow Russia
17D–204
YF-VAX®
Sanofi Pasteur, USA USA
17D–204
Yellow Fever Vaccine (live)
Beijing Tiantan Biological Products, China China
Japanese encephalitis IXIARO®
(SA14–14–2)
Inactivated Valneva SE (France), Biological E (India) Europe, USA, Canada, Hong Kong, Singapore, and Israel,
Norway, Liechtenstein, and Iceland.
JESPECT® Inactivated   Australia and New Zealand
CD. JEVAXTM (SA14–14–2) Live attenuated Chengdu Institute of Biological Products (China) China, Cambodia, North Korea, India, Laos, Myanmar, Nepal, South Korea, Sri Lanka, and Thailand.
IMOJEV® Live attenuated Chimeric vaccine
(prM/E genes replaced YFV–17D genes)
Sanofi Pasteur (France) Australia
THAIJEV® Thailand
Tick-borne encephalitis FSME-IMMUNE Inactivated Pfizer Vienna and Austria
Encepur GlaxoSmithKline Germany
TBE-MOSCOW Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE),Moscow Russia
EnceVir Microgen, Tomsk, Russia Russia
CIBP Changchun Institute of Biological Products, China China